Ascensia picks up global commercialization & distribution of ... | 合法醫療器材資訊網

2020年8月11日—IntheU.S.,AscensiawillbeginjointmarketingandsalesoftheCGMswithSenseonicswithinthenextfewmonths,andwillbetakingoverfull- ...

Continuous glucose monitoring (CGM) system-maker Senseonics has cut a deal with Ascensia Diabetes Care and its parent company, PHC Holdings, outlining commercialization and distribution of the Eversense product line over the next few years.

According to the companies, Ascensia now holds exclusive global distribution rights for the Eversense, Eversense XL and future CGMs. The duration of the agreement is subject to product launch dates and other factors, but expected to run through 2025.

In the U.S., Ascensia will begin joint marketing and sales of the CGMs with Senseonics within the next few months, and will be taking over full-time by Q1 2021. Ascensia will take on commercialization in certain European countries once the device-makers existing distribution deals run their course.

Included in the deal is a sizable investment into the CGM company. According to the announcem...